Phase II, Malaria High-Risk Populations in Namibia

Condition:   Malaria Interventions:   Drug: Presumptive treatment with Artemether-lumefantrine (AL);   Other: Enhanced vector control Sponsors:   University of California, San Francisco;   University of Namibia;   Ministry of Health and Social Services, Namibia;   University of Texas Southwestern Medical Center;   University of Notre Dame;   London School of Hygiene and Tropical Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials